This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Balhara Y. Clozapine and bladder control. Br J Psychiatry. 2011;199(6):518-9.BalharaYClozapine and bladder controlBr J Psychiatry20111996518–910.1192/bjp.199.6.518aSearch in Google Scholar
Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549-57; discussion 1564.BarryMJFowlerFJO’LearyMPBruskewitzRCHoltgreweHLMebustWKCockettATThe American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological AssociationJ Urol199214851549–57discussion 156410.1016/S0022-5347(17)36966-5Search in Google Scholar
Bhirud M, Shah N. Clozapine induced urinary incontinence during sleep. Indian J Psychiatry. 2004;46(3):280.BhirudMShahNClozapine induced urinary incontinence during sleepIndian J Psychiatry2004463280Search in Google Scholar
Centorrino F, Baldessarini RJ, Kando JC, Frankenburg FR, Volpicelli SA, Flood JG. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol. 1994;14(2):119-25.CentorrinoFBaldessariniRJKandoJCFrankenburgFRVolpicelliSAFloodJGClozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patientsJ Clin Psychopharmacol1994142119–2510.1097/00004714-199404000-00006Search in Google Scholar
Cohen MA, Alfonso CA, Mosquera M. Development of urinary retention during treatment with clozapine and meclizin. Am J Psychiatry. 1994;151(4):619-20.CohenMAAlfonsoCAMosqueraMDevelopment of urinary retention during treatment with clozapine and meclizinAm J Psychiatry19941514619–20Search in Google Scholar
De Fazio P, Gaetano R, Caroleo M, Cerminara G, Maida F, Bruno A, Muscatello MR, Moreno MJ, Russo E, Segura-García C. Rare and very rare adverse effects of clozapine. Neuropsychiatr Dis Treat. 2015;11:1995-2003.De FazioPGaetanoRCaroleoMCerminaraGMaidaFBrunoAMuscatelloMRMorenoMJRussoESegura-GarcíaCRare and very rare adverse effects of clozapineNeuropsychiatr Dis Treat2015111995–200310.2147/NDT.S83989453221126273202Search in Google Scholar
Frankenburg FR, Kando JC, Centorrino F, Gilbert JM. Bladder dysfunction associated with clozapine therapy. J Clin Psychiatry. 1996;57(1):39-40.FrankenburgFRKandoJCCentorrinoFGilbertJMBladder dysfunction associated with clozapine therapyJ Clin Psychiatry199657139–40Search in Google Scholar
Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry. 1996;57(11):514-8.FullerMABorovickaMCJaskiwGESimonMRKwonKKonickiPEClozapine-induced urinary incontinence: incidence and treatment with ephedrineJ Clin Psychiatry19965711514–810.4088/JCP.v57n11028968299Search in Google Scholar
Harrison-Woolrych M, Coulter DM. PEM in New Zealand. In Pharmacovigilance (eds R Mann, E Andrews): 317–32. John Wiley & Sons, 2007.Harrison-WoolrychMCoulterDMPEM in New ZealandPharmacovigilance (eds R Mann, E Andrews)317–32John Wiley & Sons200710.1002/9780470059210.ch25Search in Google Scholar
Harrison-Woolrych M, Skegg K, Ashton J, Herbison P, Skegg DC Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. Br J Psychiatry. 2011;199(2):140-4.Harrison-WoolrychMSkeggKAshtonJHerbisonPSkegg DC Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort studyBr J Psychiatry20111992140–410.1192/bjp.bp.110.08747821653944Search in Google Scholar
Hsu WY, Muo CH, Ma SP, Kao CH. Association between schizophrenia and urinary incontinence: A population-based study. Psychiatry Res. 2017;248:35-39.HsuWYMuoCHMaSPKaoCHAssociation between schizophrenia and urinary incontinence: A population-based studyPsychiatry Res201724835–3910.1016/j.psychres.2016.12.01228002758Search in Google Scholar
Jeong SH, Kim JH, Ahn YM, Lee KY, Kim SW, Jung DC, Kim YS. A 2-year prospective follow-up study of lower urinary tract symptoms in patients treated with clozapine. J Clin Psychopharmacol. 2008;28(6):618-24.JeongSHKimJHAhnYMLeeKYKimSWJungDCKimYSA 2-year prospective follow-up study of lower urinary tract symptoms in patients treated with clozapineJ Clin Psychopharmacol2008286618–2410.1097/JCP.0b013e31818a6cfd19011429Search in Google Scholar
Kho KH, Nielson O. Clozapine-induced nocturnal enuresis: diagnostic and treatment issues. Psych Bulletin. 2001;25:232-233.KhoKHNielsonOClozapine-induced nocturnal enuresis: diagnostic and treatment issuesPsych Bulletin200125232–23310.1192/pb.25.6.232Search in Google Scholar
Kumar A, Chadda RK, Kumar N, Balan S, Prakash Srinivasan S. Clozapine for the treatment of neurogenic bladder. Neurourol Urodyn. 2007;26(4):537-539.KumarAChaddaRKKumarNBalanSPrakash SrinivasanSClozapine for the treatment of neurogenic bladderNeurourol Urodyn2007264537–53910.1002/nau.20399Search in Google Scholar
Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114(1):169-79.LallyJMacCabeJHAntipsychotic medication in schizophrenia: a reviewBr Med Bull20151141169–7910.1093/bmb/ldv017Search in Google Scholar
Leucht S, Cipriani A, Spineli L et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-62.LeuchtSCiprianiASpineliLet alComparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysisLancet20133829896951–6210.1016/S0140-6736(13)60733-3Search in Google Scholar
Lin CC, Bai YM, Chen JY, Lin CY, Lan TH. A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr Scand. 1999;100(2):158-61.LinCCBaiYMChenJYLinCYLanTHA retrospective study of clozapine and urinary incontinence in Chinese in-patientsActa Psychiatr Scand19991002158–6110.1111/j.1600-0447.1999.tb10837.x10480202Search in Google Scholar
Long CG, West R, Siddique R, Rigg S, Banyard E, Stillman SK, Butler S, Dolley O. Screening for incontinence in a secure psychiatric service for women. Int J Ment Health Nurs. 2015;24(6):451-9.LongCGWestRSiddiqueRRiggSBanyardEStillmanSKButlerSDolleyOScreening for incontinence in a secure psychiatric service for womenInt J Ment Health Nurs2015246451–910.1111/inm.1214126146962Search in Google Scholar
Markowitz JS, Rabkin JG, Stewart J, Tricamo E, McGrath PJ, Harrison W, Ocepek-Welikson K, Quitkin FM. Validity assessment of SAFTEE: a preliminary report. Psychopharmacol Bull. 1987;23(1):102-5.MarkowitzJSRabkinJGStewartJTricamoEMcGrathPJHarrisonWOcepek-WeliksonKQuitkinFM.Validity assessment of SAFTEE: a preliminary reportPsychopharmacol Bull1987231102–5Search in Google Scholar
Mathew VM, Dursun SM, Reveley MA. Successful treatment of urinary incontinence with clozapine in a schizophrenic patient. J Psychopharmacol. 1996;10(2):166-9.MathewVMDursunSMReveleyMASuccessful treatment of urinary incontinence with clozapine in a schizophrenic patientJ Psychopharmacol1996102166–910.1177/02698811960100021422302896Search in Google Scholar
Miyamoto S, Jarskog LF, Fleischhacker WW. New therapeutic approaches for treatment-resistant schizophrenia: a look to the future. J Psychiatr Res. 2014;58:1-6.MiyamotoSJarskogLFFleischhackerWWNew therapeutic approaches for treatment-resistant schizophrenia: a look to the futureJ Psychiatr Res2014581–610.1016/j.jpsychires.2014.07.00125070124Search in Google Scholar
Ohlsen RI, Williamson R, Yusufi B, Mullan J, Irving D, Mukherjee S, Page E, Aitchison KJ, Barnes TR. Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine. J Psychopharmacol. 2008;22(3):323-9.OhlsenRIWilliamsonRYusufiBMullanJIrvingDMukherjeeSPageEAitchisonKJBarnesTRInterrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapineJ Psychopharmacol2008223323–910.1177/026988110809106918541627Search in Google Scholar
Sagy R, Weizman A, Katz N. Pharmacological and behavioral management of some often-overlooked clozapine-induced side effects. Int Clin Psychopharmacol. 2014 Nov;29(6):313-7.SagyRWeizmanAKatzNPharmacological and behavioral management of some often-overlooked clozapine-induced side effectsInt Clin Psychopharmacol2014Nov296313–710.1097/YIC.000000000000004424932886Search in Google Scholar
Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol. 1994;9(3):207-9.WarnerJPHarveyCABarnesTRClozapine and urinary incontinenceInt Clin Psychopharmacol199493207–910.1097/00004850-199409000-000107814831Search in Google Scholar
Yeung CK, Sihoe JDY, Sit FKY, Bower W, Sreedhar B, Lau JTF. Epidemiological study of primary nocturnal enuresis (bed-wetting) in young adults in Hong Kong Hong. Kong Med J. 2008;14(Suppl 3):S28-30YeungCKSihoeJDYSitFKYBowerWSreedharBLauJTFEpidemiological study of primary nocturnal enuresis (bed-wetting) in young adults in Hong Kong HongKong Med J200814Suppl3S28–30Search in Google Scholar
Yusufi B, Mukherjee S, Flanagan R, Paton C, Dunn G, Page E, Barnes TR. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration. Int Clin Psychopharmacol. 2007;22(4):238-43.YusufiBMukherjeeSFlanaganRPatonCDunnGPageEBarnesTRPrevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentrationInt Clin Psychopharmacol2007224238–4310.1097/YIC.0b013e32819f8f1717519648Search in Google Scholar
